Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Recurrent Glioblastoma
NCT01260467Phase 2Terminated
- Sponsor
- University of Rochester
- Start
- Nov 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in glioblastoma (GBM), sponsored by University of Rochester. Started Nov 2010; status: terminated.
02
Drugs
memantine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01260467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01260467.